Skip to main content

Intelgenx Technologies Corp(IGX-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.2150
Day High0.2400
Open:0.2150
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
GlobeNewswire
IntelGenx Obtains Preliminary Efficacy Results for the โ€˜BUENAโ€™ Montelukast VersaFilmยฎ Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimerโ€™s Disease

Profile

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.